Literature DB >> 11642817

The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990.

W French Anderson, R Michael Blaese, Kenneth Culver.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Human Gene Therapy Subcommittee; National Institutes of Health; Points to Consider: Transfer of Recombinant DNA into Human Subjects

Mesh：

Substances：

Year:  1990        PMID： 11642817     DOI： 10.1089/hum.1990.1.3-331

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  26 in total

1.  Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.

Authors:  T Shimada; H Fujii; H Mitsuya; A W Nienhuis
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

2.  High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.

Authors:  B A Bunnell; L M Muul; R E Donahue; R M Blaese; R A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

3.  Animal models of human disease for gene therapy.

Authors:  J M Wilson
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

4.  My career path for developing gene therapy for blinding diseases: the importance of mentors, collaborators, and opportunities.

Authors:  Jean Bennett
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

5.  Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors:  Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal:  ILAR J       Date:  2009

Review 6.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

Review 7.  Human Cardiac Gene Therapy.

Authors:  Kiyotake Ishikawa; Thomas Weber; Roger J Hajjar
Journal:  Circ Res       Date:  2018-08-17       Impact factor: 17.367

8.  BH3-based fusion artificial peptide induces apoptosis and targets human colon cancer.

Authors:  Yongjun Liu; Yunfeng Li; Haijuan Wang; Jing Yu; Hongwei Lin; Dongkui Xu; Yang Wang; Ailing Liang; Xiao Liang; Xueyan Zhang; Ming Fu; Haili Qian; Chen Lin
Journal:  Mol Ther       Date:  2009-04-07       Impact factor: 11.454

9.  Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries.

Authors:  G Leclerc; D Gal; S Takeshita; S Nikol; L Weir; J M Isner
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 10.  New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells.

Authors:  Zita Garate; Brian R Davis; Oscar Quintana-Bustamante; Jose C Segovia
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.